Multicenter randomized trial comparing sequential with concomitant administration of doxorubicin and docetaxel as first-line treatment of metastatic breast cancer: a Spanish Breast Cancer Research Group (GEICAM-9903) phase III study. (Q40530849)
Jump to navigation
Jump to search
scientific article published on July 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Multicenter randomized trial comparing sequential with concomitant administration of doxorubicin and docetaxel as first-line treatment of metastatic breast cancer: a Spanish Breast Cancer Research Group (GEICAM-9903) phase III study. |
scientific article published on July 2004 |
Statements
Multicenter randomized trial comparing sequential with concomitant administration of doxorubicin and docetaxel as first-line treatment of metastatic breast cancer: a Spanish Breast Cancer Research Group (GEICAM-9903) phase III study (English)
Margarita Amenedo
Emilio Alba
Manuel Ramos
Encarna Adrover
Ana Balil
Carlos Jara
Agustí Barnadas
Pedro Sánchez-Rovira
Antonio Casado
Spanish Breast Cancer Research Group